AVITA Medical (ASX:AVH) appoints James Corbett as CEO

The Market Herald

2022-09-29

Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediately
Mr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience
He has been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorks
Mr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017
AVITA is up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST

Regenerative medicine company AVITA Medical (AVH) has appointed James Corbett as CEO, effective immediately.

Mr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience.

He has previously been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorks.

“Jim is an experienced strategist with significant commercial expertise that positions him well to lead AVITA Medical through its next stage of growth and beyond,” Chairman Lou Panaccio said.

“Having run a thorough process utilising a leading executive search firm, I am confident that Jim is the right leader for the company at this time.”

Mr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017.

“We are grateful to Dr Perry for his many contributions to AVITA Medical. We thank him for his commitment to AVITA Medical, its customers, employees, shareholders, and thepatients we serve,” Dr Panaccio concluded.

AVITA was up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2271763232"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2271763232\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2271763232?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-09-29 11:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2271763232","market":"us","top_or_hot":-1,"title":"AVITA Medical (ASX:AVH) appoints James Corbett as CEO","media":"The Market Herald","content":"<html><body><div>\n<ul><li>Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediately</li><li>Mr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience </li><li>He has been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorks</li><li>Mr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017</li><li>AVITA is up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST</li></ul>\n<p>Regenerative medicine company AVITA Medical (AVH) has appointed James Corbett as CEO, effective immediately. </p>\n<p>Mr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience. </p>\n<p>He has previously been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorks. </p>\n<p>“Jim is an experienced strategist with significant commercial expertise that positions him well to lead AVITA Medical through its next stage of growth and beyond,” Chairman Lou Panaccio said. </p>\n<p>“Having run a thorough process utilising a leading executive search firm, I am confident that Jim is the right leader for the company at this time.” </p>\n<p>Mr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017. </p>\n<p>“We are grateful to Dr Perry for his many contributions to AVITA Medical. We thank him for his commitment to AVITA Medical, its customers, employees, shareholders, and thepatients we serve,” Dr Panaccio concluded. </p>\n<p>AVITA was up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST.</p>\n</div></body></html>","source":"markerherald_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AVITA Medical (ASX:AVH) appoints James Corbett as CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAVITA Medical (ASX:AVH) appoints James Corbett as CEO\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Market Herald</strong><span class=\"h-time small\">2022-09-29 11:29</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div>\n<ul><li>Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediately</li><li>Mr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience </li><li>He has been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorks</li><li>Mr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017</li><li>AVITA is up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST</li></ul>\n<p>Regenerative medicine company AVITA Medical (AVH) has appointed James Corbett as CEO, effective immediately. </p>\n<p>Mr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience. </p>\n<p>He has previously been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorks. </p>\n<p>“Jim is an experienced strategist with significant commercial expertise that positions him well to lead AVITA Medical through its next stage of growth and beyond,” Chairman Lou Panaccio said. </p>\n<p>“Having run a thorough process utilising a leading executive search firm, I am confident that Jim is the right leader for the company at this time.” </p>\n<p>Mr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017. </p>\n<p>“We are grateful to Dr Perry for his many contributions to AVITA Medical. We thank him for his commitment to AVITA Medical, its customers, employees, shareholders, and thepatients we serve,” Dr Panaccio concluded. </p>\n<p>AVITA was up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST.</p>\n</div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://themarketherald.com.au/avita-medical-asxavh-appoints-james-corbett-as-ceo-2022-09-29/\">The Market Herald</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XKO.AU","symbol_name":"標普/澳交所 300指數","start_time":0,"source_url":"https://themarketherald.com.au/avita-medical-asxavh-appoints-james-corbett-as-ceo-2022-09-29/","article_id":"2271763232","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2271763232","pubTimestamp":1664422140,"columns":[],"sourceInfo":{"source_id":"markerherald_stock","name":"The Market Herald"},"weMediaInfo":null,"summary":"Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediate","collect":0,"end_time":0,"defaultTopTitle":"themarketherald.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"XKO.AU":"标普/澳交所 300指数","BK7039":"金融交易所和数据","XAO.AU":"标普/澳交所 普通股指数","ASX.AU":"ASX LTD","ASX":"日月光半导体","XJO.AU":"标普/澳交所 200指数","AVH.AU":"Avita Therapeutics","BK7508":"医药生物股","BK4526":"热门中概股","BK7067":"生物科技","BK4141":"半导体产品"},"translate_title":"AVITA医疗公司（ASX：AVH）任命詹姆斯·科比特为首席执行官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ASX":1,"ASX.AU":1,"AVH":1,"AVH.AU":1,"XAO.AU":1,"XJO.AU":1,"XKO.AU":1},"content_text":"Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediatelyMr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience He has been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorksMr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017AVITA is up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST\nRegenerative medicine company AVITA Medical (AVH) has appointed James Corbett as CEO, effective immediately. \nMr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience. \nHe has previously been CEO of publicly traded companies Microtherapeutics, ev3 Inc and Alphatec Spine, and private companies Home Diagnostics Inc, Vertos Medical Inc and CathWorks. \n“Jim is an experienced strategist with significant commercial expertise that positions him well to lead AVITA Medical through its next stage of growth and beyond,” Chairman Lou Panaccio said. \n“Having run a thorough process utilising a leading executive search firm, I am confident that Jim is the right leader for the company at this time.” \nMr Corbett will be replacing Dr Michael Perry who served as CEO and Executive Director since June 2017. \n“We are grateful to Dr Perry for his many contributions to AVITA Medical. We thank him for his commitment to AVITA Medical, its customers, employees, shareholders, and thepatients we serve,” Dr Panaccio concluded. \nAVITA was up 3.12 per cent on the market with shares trading at $1.74 at 1:28 pm AEST.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}